Baird Financial Group Inc. Buys 11,099 Shares of CVS Health Corporation $CVS

Baird Financial Group Inc. lifted its stake in shares of CVS Health Corporation (NYSE:CVS) by 3.9% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 297,802 shares of the pharmacy operator’s stock after acquiring an additional 11,099 shares during the quarter. Baird Financial Group Inc.’s holdings in CVS Health were worth $20,542,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also added to or reduced their stakes in the company. Vanguard Group Inc. lifted its position in shares of CVS Health by 1.7% in the 2nd quarter. Vanguard Group Inc. now owns 120,399,131 shares of the pharmacy operator’s stock worth $8,305,132,000 after purchasing an additional 2,063,737 shares during the period. Dodge & Cox raised its stake in CVS Health by 4.8% during the first quarter. Dodge & Cox now owns 73,459,122 shares of the pharmacy operator’s stock worth $4,976,856,000 after buying an additional 3,353,223 shares during the last quarter. Geode Capital Management LLC lifted its holdings in CVS Health by 2.4% in the second quarter. Geode Capital Management LLC now owns 28,635,233 shares of the pharmacy operator’s stock valued at $1,966,083,000 after buying an additional 675,824 shares during the period. Invesco Ltd. boosted its position in CVS Health by 15.3% during the second quarter. Invesco Ltd. now owns 23,532,479 shares of the pharmacy operator’s stock valued at $1,623,270,000 after acquiring an additional 3,118,626 shares during the last quarter. Finally, Norges Bank acquired a new stake in CVS Health during the 2nd quarter worth about $1,358,698,000. 80.66% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several equities research analysts recently commented on CVS shares. Royal Bank Of Canada restated an “outperform” rating on shares of CVS Health in a research report on Thursday. The Goldman Sachs Group started coverage on shares of CVS Health in a research report on Tuesday, October 14th. They set a “buy” rating and a $91.00 price objective for the company. Wall Street Zen lowered shares of CVS Health from a “buy” rating to a “hold” rating in a research note on Saturday, November 1st. Baird R W raised shares of CVS Health from a “hold” rating to a “strong-buy” rating in a research note on Thursday, August 14th. Finally, Weiss Ratings reiterated a “hold (c-)” rating on shares of CVS Health in a report on Monday, December 1st. Two equities research analysts have rated the stock with a Strong Buy rating, twenty have assigned a Buy rating and four have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $90.95.

CVS Health Price Performance

Shares of NYSE CVS opened at $75.52 on Friday. The stock has a market cap of $95.87 billion, a price-to-earnings ratio of 198.74, a PEG ratio of 0.74 and a beta of 0.48. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.63 and a current ratio of 0.83. CVS Health Corporation has a fifty-two week low of $43.56 and a fifty-two week high of $85.15. The firm’s 50-day simple moving average is $78.75 and its 200 day simple moving average is $71.29.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Wednesday, October 29th. The pharmacy operator reported $1.60 EPS for the quarter, topping the consensus estimate of $1.36 by $0.24. The firm had revenue of $102.87 billion during the quarter, compared to the consensus estimate of $98.85 billion. CVS Health had a return on equity of 11.45% and a net margin of 0.12%.The company’s quarterly revenue was up 7.8% compared to the same quarter last year. During the same period in the prior year, the business posted $1.09 earnings per share. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. As a group, research analysts anticipate that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, November 3rd. Shareholders of record on Thursday, October 23rd were issued a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a yield of 3.5%. The ex-dividend date of this dividend was Thursday, October 23rd. CVS Health’s payout ratio is currently 700.00%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.